Mitsui Chemicals’ newly formed $36.8m 321Force unit will focus on healthcare, mobility, ICT and sustainable materials.

The Japanese chemicals manufacturer Mitsui Chemicals has partnered venture capital firm Global Brain to launch a ¥5bn ($36.8m) investment vehicle. The fund, named 321Force, will invest in seed-stage companies that dovetail with Mitsui Chemicals’ four areas of focus – life and healthcare, mobility, information and communications technology, and sustainable materials. It will also target new…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.